Abstract
In this study, the 4-week oral toxicity and anti-cancer activity of the hexane layer of Melia azedarach L. var. japonica Makino’s bark extract were investigated. We carried out a hollow fiber (HF) assay and 28- day repeated toxicity study to confirm the anti-cancer effect and safety of the hexane layer. The HF assay was carried out using an A549 human adenocarcinoma cell via intraperitoneal (IP) site with or without cisplatin. In the result, the 200 mg/kg b.w of hexane layer with 4 mg/kg b.w of cisplatin treated group, showed the highest cytotoxicity aginst A549 carcinoma cells. For the 28-day repeated toxicity study, 6 groups of 10 male and female mice were given by gavage 200, 100, or 50 mg/kg b.w hexane layer with or without 4 mg/kg b.w of cisplatin against body weight, and were then sacrificed for blood and tissue sampling. The subacute oral toxicity study in mice with doses of 200, 100, and 50 mg/kg b.w hexane layer showed no significant changes in body weight gain and general behavior. The cisplatin-treated group significantly decreased in body weight compared to the control group but regained weight with 100 and 200 mg/kg b.w of hexane layer. The biochemical analysis showed significant increase in several parameters (ALT, total billirubin, AST, creatinine, and BUN) in cisplatin-treated groups. However, in the group given a co-treatment of hexane layer (200 mg/kg b.w), levels of these parameters decreased. In hematological analysis, cisplatin induced the reduction of WBCs and neutrophils but co-treatment with hexane layer (100 and 200 mg/kg b.w) improved these toxicities caused by cisplatin. The histological profile of the livers showed eosinophilic cell foci in central vein and portal triad in cisplatin treated mice. These results show that hexane layer might have an anti-cancer activity and could improve the toxicity of cisplatin.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Baguley, B.C. and Nash, R. (1981). Antitumour activity of substituted 9-anilinoacridines-comparison of in vivo and in vitro testing systems. Eur. J. Cancer, 17, 671–679.
Boyd, M.R. (1989). Status of the NCI preclinical antitumor drug discovery screen. Principles and Practice of Oncology, 3, 1–12.
Céspedes, C.L., Alarcón, J., Aranda, E., Becerra, J. and Silva, M. (2001). Insect growth regulator and insecticidal activity of betadihydroagarofurans from Maytenus spp. (Celastraceae). Z. Naturforsch C., 56, 603–613.
Cha, S.M. (1977). Potential anticancer medicinal plants. A statistical evaluation of their frequencies of appearance in oriental medicine formularies. Kor. J. Pharmacogn., 8, 1–15.
Ford, R.A., Letizia, C. and Api, A.M., (1988). Monographs on fragrance raw materials. Food Chem. Toxicol., 26, 273–415.
Geran, R.I., Greenberg, N.H., Macdonald, M.M. and Abbott, B.J. (1977). Modified protocol for the testing of new synthetics in the L1210 lymphoid leukemia murine model in the DR&D program, DCT, NCI. Natl. Cancer Inst. Monogr., 45, 151–153.
Gonzalez, V.M., Fuertes, M.A., Alonso, C. and Perez, J.M. (2001). Is cisplatin-induced cell death always produced by apoptosis? Mol. Pharmacol., 59, 657–663.
Hong, M.H. (1972). Statistical studies on the formularies of oriental medicine (1) prescription frequency and their origin distribution of herb drugs. Kor. J. Pharmacogn., 3, 57–64.
Hwang, W.I., Lee, S.D. and Oh, S.K. (1982). A study on the pharmacological activities of Korean medicinal herbs mainly on the antitumor activities (in Korean). Kor. Biochem. J., 15, 205–219.
Hwang, W.I. and Oh, S.K. (1984). Effects of petroleum ether extract of ginseng root on same enzyme activity in human colon cancer cells. Kor. J. Ginseng Sci., 8, 153–166.
Itokawa, H., Qiao, Z.S., Hirobe, C. and Takeya, K. (1995). Cytotoxic limonoids and tetranortriterpenoids from Melia azedarach. Chem. Pharm. Bull., 43, 1171–1175.
Keshri, G., Lakshmi, V. and Singh, M.M. (2003). Pregnancy interceptive activity of Melia azedarach Linn. in adult female Sprague-Dawley rats. Contraception, 68, 303–306.
Khan, M.R., Kihara, M. and Omoloso, A.D. (2001). Antimicrobial activity of Horsfieldia helwigii and Melia azedarach. Fitoterapia, 72, 423–427.
Kim, H.W. and Kang, S.C (2009). Anti-cancer activities of extract from the bark of Melia azedarach L. var. japonica Makino. Kor. J. Plant Resources, 22, 312–316.
Kwon, H.C., Lee, B.G., Kim, S.H., Jung, C.M., Hong, S.Y., Han, J.W., Lee, H.W., Zee, O.P. and Lee, K.R. (1999). Inducible nitric oxide synthase inhibitors from Melia azedarach var. japonica. Arch. Pharm. Res., 22, 410–413.
Lee, B.G., Kim, S.H., Zee, O.P., Lee, K.R., Lee, H.Y., Han, J.W. and Lee, H.W. (2000). Suppression of inducible nitric oxide synthase expression in RAW 264. 7 macrophages by two betacarboline alkaloids extracted from Melia azedarach. Eur. J. Pharmacol., 406, 301–309.
Losa, J.H., Parada Cobo, C., Viniegra, J.G., Sanchez-Arevalo Lobo, V.J., Ramon y Cajal, S. and Sanchez-Prieto, R. (2003). Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene, 22, 3998–4006.
Miyazaki, T. and Nishijima, M. (1981). Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem. Pharm. Bull., 29, 3611–3616.
Son, H.S. and Hwang, W.I. (1990). A study on the cytotoxic activity of garlic (Allium sativum) extract against cancer cells (in Korean). Kor. J. Nutrition, 23, 135–147.
Takeya, K., Quio, Z.S., Hirobe, C. and Itokawa, H. (1996a). Cytotoxic trichilin-type limonoids from Melia azedarach. Bioorg. Med. Chem., 4, 1355–1359.
Takeya, K., Qiao, Z.S., Hirobe, C. and Itokawa, H. (1996b). Cytotoxic azadirachtin-type limonoids from Melia azedarach. Phytochemistry, 42, 709–712.
Thayer, P.S., Himmelfarb, P. and Watts, G.L. (1971). Cytotoxicity assays with L1210 cells in vitro: comparison with L1210 in vivo and KB cells in vitro. Cancer Chemother. Rep. 2, 2, 1–25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kim, H.W., Kang, S.C. The Toxicity and Anti-cancer Activity of the Hexane Layer of Melia azedarach L. var. japonica Makino’s Bark Extract. Toxicol Res. 28, 57–65 (2012). https://doi.org/10.5487/TR.2012.28.1.057
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2012.28.1.057